AKT1 and esophageal squamous cell carcinoma: There are many abnormal mutations in PI3K/Akt/mTOR pathway, such as PIK3CA and Akt subtype mutations, which can activate PI3K/Akt/mTOR pathway and affect the occurrence of ESCC.